NuOncology Labs Overview

  • Status
  • Public
  • Employees
  • 1
  • Stock Symbol
Stock Symbol
  • Share Price
  • $297.00
  • (As of Tuesday Closing)

NuOncology Labs General Information


Taihe Group Inc formerly, NuOncology Labs Inc is a United States based company and provides predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. NLAB's operations include development, identification, testing and licensing of cancer treatment compounds.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Drug Discovery
Other Industries
Stock Exchange
Primary Office
  • 4870 Haygood Road
  • Suite 107
  • Virginia Beach, VA 23455
  • United States
+1 (757) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NuOncology Labs Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$297.00 $300.00 $968K 3.26K 6.09 -$9.00

NuOncology Labs Financials Summary

In Thousands,
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 2,973
Revenue 0 0 0
EBITDA (42) (29) 0
Net Income (42) (29) 0
Total Assets 0 0 0
Total Debt 12
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NuOncology Labs Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial